Advertisement

Rheumaderm pp 309-316 | Cite as

Biomechanical Stimulation Therapy

A Novel Physiotherapy Method for Systemic Sclerosis
  • T. Klyscz
  • G. Rassner
  • G. Guckenberger
  • M. Jünger
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 455)

Abstract

To improve the mobility of joints, particularly of the finger joints and the mandibular joints and to reduce the edema of the skin, various physical therapies have to be used in patients with SSc. As the quality of patients’ life depends on the use of their fingers and of their mouth, these therapeutics belong to the basic measures in the treatment of SSc. In addition to the manually performed lymph drainage a new method1, the biomechanical stimulation therapy, has proven to be efficacious to improve the mobility of the joints and to reduce the edema in SSc-patients. By devices of various size, longitudinal vibrations are transduced to patients’ body: finger, hand, face, mandibular joint, the oral mucosa, the legs and the trunk. In 6 patients we found: significant (p<0.05) increase of skin score, grip strength, mobility of joints (10–30%). No side effects were observed.

We conclude from these data, that skin, mucosa, joints and patients’ quality of life are improved by the biomechanical stimulation therapy in a clinical relevant degree.

Keywords

Systemic Sclerosis Mechanical Vibration Mandibular Joint Longitudinal Vibration Skin Score 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Atha J, Wheatley B. Joint mobility changes due to low frequency vibration and stretching exercise. British Journal of Sport Medicine 10: 26–34 (1976).CrossRefGoogle Scholar
  2. 2.
    Biermann, W. Influence of cycloid vibration massage on trunk flexion. Am J Physical Med 39: 219–224 (1960).Google Scholar
  3. 3.
    Black CM. Scleroderma and fasciitis in children. Current Opinion in Rheumatology 7: 442–448 (1995).PubMedCrossRefGoogle Scholar
  4. 4.
    Brammer AJ. Dose-response relationship for handtransmitted vibration. Scandinavian Journal of Work, Environment and Health 12: 284–288 (1986).PubMedCrossRefGoogle Scholar
  5. 5.
    Clements PJ, Lachenbruch PA, Sterz M, Danovitch G, Hawkins R, Ippoliti A, Paulus HE. Cyclosporine in systemic sclerosis. Arthritis and Rheumatism 36(1): 75–83 (1993).PubMedCrossRefGoogle Scholar
  6. 6.
    Cribier B, Faradji T, Le Coz C, Oberling F, Grosshans E. Extracorporeal Photochemotherapy in systemic sclerosis and morphea. Dermatology 191: 25–31 (1995).PubMedCrossRefGoogle Scholar
  7. 7.
    Di Spaltro F, Cottrill C. Extracorporal photochemotherapy in progressive systemic sclerosis. International Journal of Dermatology 32: 417–420 (1993).PubMedCrossRefGoogle Scholar
  8. 8.
    Eklund G, Hagbarth KE. Normal variability of tonic vibration reflexes in man. Experimental Neurology 16:80–92.(1966)PubMedCrossRefGoogle Scholar
  9. 9.
    Feghali CA, Bost KL, Boulware DW, Levy LS. Machanisms of pathogenesis in scleroderma. Overproduction of interleukin 6 by fibroblasts cultured from affected skin sites of patients with scleroderma. Journal Rheumatology 19:1207–11 (1992).Google Scholar
  10. 10.
    Fox EL, Matthew DK. The physiological basis of physical education and athletics. Philadelphia, Saunders College Publishers, 1981.Google Scholar
  11. 11.
    Gelber AC, Wigley FM. Treatment of scleroderma. Current opinions in Rheumatology 7: 551–559 (1995).CrossRefGoogle Scholar
  12. 12.
    Homma S, Kabayashi H, Watanabe S. Vibratory stimulation of muscle and stretch reflex. Japanese Journal of Physiology 20: 309–319 (1970).PubMedCrossRefGoogle Scholar
  13. 13.
    Issurin VB, Liebermann DG, Tenenbaum G. Effect of vibratory stimulation training on maximal force and flexibility. Journal of Sports Science 12: 561–566 (1994).CrossRefGoogle Scholar
  14. 14.
    Klyscz T, Breuer J, Jünger M, Rassner G. Systemic scleroderma in a 16 year-old boy: the diagnostic relevance of capillaroscopy and fluorescence video microscopy. European Journal of Dermatology 7: 381–384 (1997).Google Scholar
  15. 15.
    Klyscz T, Ritter-Schempp C, Jünger M, Rassner G. Biomechanische Stimulationstherapie (BMS) zur physikalischen Behandlung des arthrogenen Stauungssyndroms. Hautarzt 48: 318–322 (1997)PubMedCrossRefGoogle Scholar
  16. 16.
    Klyscz T, Jünger M, Meyer H, Rassner G. Improvement of acral circulation in a patient with systemic sclerosis with stellate blocks. VASA 27: 39–42 (1998).PubMedGoogle Scholar
  17. 17.
    Lundeberg T, Nordemar R, Ottoson D. Pain alleviation by vibratory stimulation. Pain 20: 25–44 (1984).PubMedCrossRefGoogle Scholar
  18. 18.
    Mauch C, Eckes B, Hunzelmann N, Oono T, Kozlowska E, Krieg T. Control of fibrosis in systemic scleroderma. Journal of Investigative Dermatology. 100(1): 92S–96S (1993).PubMedCrossRefGoogle Scholar
  19. 19.
    Mauch C, Krieg T, Bauer EA. Role of the extracellular matrix in the degradation of connective tissue. Archieves of Dermatologic Research. 287: 107–114 (1994).CrossRefGoogle Scholar
  20. 20.
    Miyashita K, Shiomi S, Itoh N, Kasamatsu T, Iwata H. Epidemiological study of vibration syndrome in response to total hand-tool-operating time. British Journal of Industrial Medicine 40: 92–98 (1983).PubMedGoogle Scholar
  21. 21.
    Müller-Ladner U, Benning K, Lang B. Current therapy of systemic sclerosis (scleroderma). Clinical Investigator 71: 257–263 (1993).PubMedGoogle Scholar
  22. 22.
    Nazarov V, Spivak G. Developement of athlete’s strength abilities by means of biomechanical stimulation method. Theory and Practice of Physical Culture (Moscow) 12: 37–39 (1987).Google Scholar
  23. 23.
    Perez MI, Kohn SR. Systemic sclerosis. Journal of the American Academy of Dermatology. 28: 525–547 (1993).PubMedCrossRefGoogle Scholar
  24. 24.
    Rook AH, Freundlich B, Jegasothy BV et al. Treatment of systemic sclerosis with extracorporeal photochemotherapy. Archives of Dermatology 128: 337–46 (1992).PubMedCrossRefGoogle Scholar
  25. 25.
    Samuelson B, Jorfieldt L, Ahlborg B. Influence of vibration on endurance of maximal isometric contraction. Clinical Physiology 9: 21–25 (1989).PubMedCrossRefGoogle Scholar
  26. 26.
    Scharffetter K, Kind P, Wollny-Protzel D, Schuppe HC, Lakomek HJ, Goerz G. Die Sklerodermien. H+G Zeitschrift für Hautkrankheiten 65(3) 237–246 (1990).Google Scholar
  27. 27.
    Sollberg S, Krieg T. Systemische Sklerodermie. Hautarzt 1995. 46: 587–601.PubMedCrossRefGoogle Scholar
  28. 28.
    Steen VD, Medsger TA, Rodnan GP. D-Penicillamine therapy in progrressive systemic sclerosis (scleroderma). A retrospective analysis. Annals of Internal Medicine 97: 652–659 (1982).PubMedGoogle Scholar
  29. 29.
    van den Hoogen FHJ, de Jong EMG. Clinical aspects of systemic and localized scleroderma. Current opinion in Rheumatology 7: 546–550 (1995).PubMedCrossRefGoogle Scholar
  30. 30.
    White B. Immunologic aspects of scleroderma. Current Opinions in Rheumatology 7: 541–545 (1995).CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1999

Authors and Affiliations

  • T. Klyscz
    • 1
  • G. Rassner
    • 1
  • G. Guckenberger
    • 1
  • M. Jünger
    • 1
  1. 1.Department of DermatologyUniversity Hospital of TübingenTübingenGermany

Personalised recommendations